Oncology
Accelerating the development of cancer treatments through TRACER’s distinctive research approach.
Therapeutic areas of clinical research and preclinical studies
TRACER’s services span a broad range of therapeutic areas in clinical research and preclinical studies. Many of our studies focus on oncology, one of the most common therapeutic areas in clinical trials with radiopharmaceuticals. However, molecular imaging with radiolabeled compounds can also provide valuable insights in different therapeutic areas, including cardiovascular, inflammatory, neurological, and infectious diseases.
Whatever the therapeutic target or disease area, TRACER can design and conduct imaging studies that deliver visual and quantitative data on your drug’s behavior in the relevant patient population.
Contact us to learn how clinical trials with radiopharmaceuticals and imaging studies with radiolabeled drugs can support your drug development program.
Therapeutic expertise
Inflammation
Helping developers advance anti-inflammatory treatments with rapid research and precise molecular imaging insights.
Infectious diseases
Advancing bacterial infection diagnosis, therapy, and treatment monitoring through molecular imaging.
Cardiovascular
Supporting cardiovascular research with a disease model studied directly in humans.
Contact TRACER to discuss clinical trials or preclinical studies in your therapeutic area.